U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
166261166261Risk Assessment of Long-Haul Truck DriversCompletedNo Results AvailableGonorrhea|Chlamydia Infections|Hepatitis B|Hepatitis C|Diabetes Mellitus|Hypertension|Obesity|HIV Infections|Hyperlipidemiahttps://ClinicalTrials.gov/show/NCT00381992
166262166262Supportive Expressive Therapy for Depressed and Anxious AdolescentsSuspendedNo Results AvailableDepression|AnxietyProcedure: Supportive Expressive Therapyhttps://ClinicalTrials.gov/show/NCT00381979
166263166263Study of Robotic Template Guidance for Needle Placement in Transperineal Prostate BrachytherapyCompletedNo Results AvailableProstate CancerDevice: robotic placement devicehttps://ClinicalTrials.gov/show/NCT00381966
166264166264High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCVCompletedNo Results AvailableHepatitis CDrug: Peginterferon alfa-2a|Drug: Interferon alfa-2a|Drug: Ribavirinhttps://ClinicalTrials.gov/show/NCT00381953
166265166265Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous TherapyCompletedHas ResultsAdult Lymphocyte Depletion Hodgkin Lymphoma|Adult Lymphocyte Predominant Hodgkin Lymphoma|Adult Mixed Cellularity Hodgkin Lymphoma|Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma|Adult Nodular Sclerosis Hodgkin Lymphoma|Childhood Lymphocyte DepletioDrug: ifosfamide|Drug: bortezomib|Drug: vinorelbine tartrate|Biological: filgrastimhttps://ClinicalTrials.gov/show/NCT00381940
166266166266Effect of Counseling on Psychological Stress Amongst Women Felt to be at High Risk for Breast Cancer DevelopmentCompletedNo Results AvailableBreast CancerBehavioral: Physician Counselinghttps://ClinicalTrials.gov/show/NCT00381927
166267166267Vitamin D Dose-Response Study to Establish Dietary Requirements in InfantsCompletedNo Results AvailableVitamin D DeficiencyDrug: Vitamin D|Drug: Vitamin D|Drug: Vitamin Dhttps://ClinicalTrials.gov/show/NCT00381914
166268166268Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By SurgeryCompletedNo Results AvailableBreast CancerBiological: trastuzumab|Genetic: polymorphism analysis|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00381901
166269166269Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic CancerCompletedHas ResultsCervical Cancer|Endometrial Cancer|Fallopian Tube Cancer|Ovarian Cancer|Sarcoma|Thromboembolism|Vaginal Cancer|Vulvar CancerDrug: fondaparinux sodiumhttps://ClinicalTrials.gov/show/NCT00381888
166270166270Vaccine Therapy, Incomplete Freund's Adjuvant, and GM-CSF in Treating Patients With HIVCompletedNo Results AvailableNonneoplastic ConditionBiological: E1M184V peptide vaccine|Biological: incomplete Freund's adjuvant|Biological: sargramostim|Other: immunoenzyme techniquehttps://ClinicalTrials.gov/show/NCT00381875
166271166271Phase II Trial Evaluating the Efficacy and Tolerability of Aprepitant & Palonosetron for Prevention of Chemotherapy-Induced Nausea and VomitingCompletedHas ResultsColorectal Cancer|Nausea and VomitingDrug: aprepitant|Drug: dexamethasone|Drug: fluorouracil|Drug: irinotecan hydrochloride|Drug: leucovorin calcium|Drug: oxaliplatin|Drug: palonosetron hydrochloride|Procedure: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT00381862
166272166272Use of an Herbal Preparation to Prevent and Dissolve Kidney StonesCompletedHas ResultsCystinuria|Nephrolithiasis, Calcium OxalateDrug: Cystone|Drug: Sugar Pill (Placebo)https://ClinicalTrials.gov/show/NCT00381849
166273166273Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate CancerActive, not recruitingNo Results AvailableProstatic Neoplasms|AnemiaDrug: Darbepoetin Alfahttps://ClinicalTrials.gov/show/NCT00381836
166274166274Healthy Outcomes of Pregnancy EducationActive, not recruitingNo Results AvailableEnvironmental Tobacco Smoke Exposure|Depression|Partner Abuse|Tobacco SmokingBehavioral: Cognitive Behavioral Therapyhttps://ClinicalTrials.gov/show/NCT00381823
166275166275A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus ErythematosusTerminatedHas ResultsLupus Erythematosus, SystemicDrug: Rituximab|Drug: Methylprednisolone|Drug: Acetaminophen|Drug: Diphenhydraminehttps://ClinicalTrials.gov/show/NCT00381810
166276166276Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade GliomaActive, not recruitingHas ResultsChildhood Cerebral Anaplastic Astrocytoma|Childhood Oligodendroglioma|Childhood Spinal Cord Neoplasm|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Ependymoma|Recurrent Childhood MedulloblastomaBiological: Bevacizumab|Radiation: Fludeoxyglucose F-18|Drug: Irinotecan Hydrochloridehttps://ClinicalTrials.gov/show/NCT00381797
166277166277C2P - Phase III: MPowerment and Community PromiseCompletedNo Results AvailableHIV InfectionsBehavioral: Printed materials|Behavioral: Peer advocateshttps://ClinicalTrials.gov/show/NCT00381784
166278166278Prevalence of Salivary Hypofunction in Patients With Globus PharyngeusCompletedNo Results AvailableGlobus PharyngeusBehavioral: Conservative management for xerostomiahttps://ClinicalTrials.gov/show/NCT00381771
166279166279The COMACS Study: A Comparison of Methylphenidates in an Analog Classroom SettingCompletedNo Results AvailableAttention Deficit Hyperactivity DisorderDrug: Methylphenidate Extended Release Capsuleshttps://ClinicalTrials.gov/show/NCT00381758
166280166280A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile DysfunctionCompletedNo Results AvailableErectile DysfunctionDrug: tadalafil|Drug: placebohttps://ClinicalTrials.gov/show/NCT00381732
166281166281Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral NeuropathyCompletedNo Results AvailableDiabetic Neuropathy, PainfulDrug: AGN 203818|Drug: AGN 203818|Drug: AGN 203818|Drug: placebo capsulehttps://ClinicalTrials.gov/show/NCT00381719
166282166282Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction CancerActive, not recruitingNo Results AvailableEsophageal CancerBiological: cetuximab|Drug: ECF|Drug: IC|Drug: FOLFOXhttps://ClinicalTrials.gov/show/NCT00381706
166283166283Azacitidine in Treating Patients With MyelofibrosisTerminatedHas ResultsChronic Myeloproliferative Disorders|Secondary MyelofibrosisDrug: azacitidinehttps://ClinicalTrials.gov/show/NCT00381693
166284166284Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic LeukemiaActive, not recruitingNo Results AvailableB-cell Childhood Acute Lymphoblastic Leukemia|L1 Childhood Acute Lymphoblastic Leukemia|L2 Childhood Acute Lymphoblastic Leukemia|Intermediate Risk Recurrent Childhood Acute Lymphoblastic LeukemiaDrug: vincristine sulfate|Drug: prednisone|Drug: doxorubicin hydrochloride|Drug: pegaspargase|Drug: cytarabine|Drug: methotrexate|Drug: dexamethasone|Drug: etoposide|Drug: cyclophosphamide|Drug: leucovorin calcium|Biological: filgrastim|Drug: asparaginase|Drug: mercaptopurinehttps://ClinicalTrials.gov/show/NCT00381680
166285166285Study to Assess GW642444 in Asthma PatientsCompletedNo Results AvailablePulmonary Disease, Chronic Obstructive|AsthmaDrug: GW642444M|Drug: GW642444H|Other: placebohttps://ClinicalTrials.gov/show/NCT00381667
166286166286Safety/Tolerability Study of AV-412 in Subjects With Refractory or Relapsed Solid Tumor MalignanciesTerminatedNo Results AvailableTumorDrug: AV-412https://ClinicalTrials.gov/show/NCT00381654
166287166287Sunitinib in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by SurgeryActive, not recruitingNo Results AvailableRecurrent Thyroid Gland Carcinoma|Stage III Thyroid Gland Follicular Carcinoma|Stage IVA Thyroid Gland Follicular Carcinoma|Stage IVA Thyroid Gland Papillary Carcinoma|Stage IVB Thyroid Gland Follicular Carcinoma|Stage IVB Thyroid Gland Papillary CarcinomOther: Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Sunitinib Malatehttps://ClinicalTrials.gov/show/NCT00381641
166288166288Nasal Epithelial Cells/Blood Lymphocyte Markers for Cystic Fibrosis (CF)/CF Pulmonary ExacerbationsCompletedNo Results AvailableCystic FibrosisProcedure: epithelial cells and blood lymphocyte extractionhttps://ClinicalTrials.gov/show/NCT00381628
166289166289Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy StudyCompletedNo Results AvailableHealthyBiological: Serogroup B meningococcal Vaccinehttps://ClinicalTrials.gov/show/NCT00381615
166290166290A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in Subjects With ESRD on HemodialysisTerminatedNo Results AvailableEnd Stage Renal DiseaseDrug: GHRP-1/AG 70 mg depot in ESRD|Other: Placebohttps://ClinicalTrials.gov/show/NCT00381602

* Görseller ve İçerik tekif hakkına sahip olabilir